{"filing":{"accession_number":"0001193125-26-280243","cik":"0001770069","ticker":"MPLT","company_name":"MapLight Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-24","report_date":null,"primary_document":"d119921d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526280243/d119921d8k.htm"},"events":[{"id":13358,"run_id":11865,"accession_number":"0001193125-26-280243","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from MapLight Therapeutics' 2026 annual meeting held on June 23, 2026. The filing reports voting outcomes for two proposals: (1) election of three directors (Martin Babler, Troy Cox, and George Pavlov), all of whom were elected, and (2) ratification of RSM US LLP as the independent auditor for fiscal year 2026, which passed with overwhelming support. This is a routine but material governance disclosure required under Item 5.07.","company_name":"MapLight Therapeutics, Inc.","ticker":"MPLT","filing_date":"2026-06-24","form":"8-K","submitted_at":null,"items":[{"id":10481,"accession_number":"0001193125-26-280243","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from MapLight Therapeutics' 2026 annual meeting held on June 23, 2026. The filing reports voting outcomes for two proposals: (1) election of three directors (Martin Babler, Troy Cox, and George Pavlov), all of whom were elected, and (2) ratification of RSM US LLP as the independent auditor for fiscal year 2026, which passed with overwhelming support. This is a routine but material governance disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T11:13:40.246084+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10481,"accession_number":"0001193125-26-280243","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from MapLight Therapeutics' 2026 annual meeting held on June 23, 2026. The filing reports voting outcomes for two proposals: (1) election of three directors (Martin Babler, Troy Cox, and George Pavlov), all of whom were elected, and (2) ratification of RSM US LLP as the independent auditor for fiscal year 2026, which passed with overwhelming support. This is a routine but material governance disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T11:13:40.246084+00:00","company_name":"MapLight Therapeutics, Inc.","ticker":"MPLT","filing_date":"2026-06-24"}]}